These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18171631)

  • 1. Telomerase inhibition: the way ahead for cancer therapy in humans and dogs?
    Colitz CM
    Vet J; 2008 Aug; 177(2):153-4. PubMed ID: 18171631
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies.
    Lund JR; Paoloni M; Kurzman I; Padilla M; Argyle DJ
    Vet J; 2008 Aug; 177(2):192-7. PubMed ID: 17981480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer researchers usher in dog days of medicine.
    Mack GS
    Nat Med; 2005 Oct; 11(10):1018. PubMed ID: 16211022
    [No Abstract]   [Full Text] [Related]  

  • 4. Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect.
    Tauchi T; Ohyashiki JH; Ohyashiki K
    Methods Mol Biol; 2007; 405():181-9. PubMed ID: 18369825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials going to the dogs: canine program to study tumor treatment, biology.
    Mack GS
    J Natl Cancer Inst; 2006 Feb; 98(3):161-2. PubMed ID: 16449674
    [No Abstract]   [Full Text] [Related]  

  • 6. Fighting cancer in dogs. Morris Animal Foundation leads campaign to find cures.
    Rezendes A
    J Am Vet Med Assoc; 2007 May; 230(9):1287-8. PubMed ID: 17489135
    [No Abstract]   [Full Text] [Related]  

  • 7. Telomerase: A missing link between ageing, cancer and novel therapies?
    Argyle DJ
    Vet J; 2008 Feb; 175(2):149-50. PubMed ID: 17446098
    [No Abstract]   [Full Text] [Related]  

  • 8. No end in sight for telomerase-targeted cancer drugs.
    Williams SC
    Nat Med; 2013 Jan; 19(1):6. PubMed ID: 23295993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nonsurgical therapy of tumors in dogs. (Preliminary report)].
    Jirina K
    Arch Exp Veterinarmed; 1971 Aug; 25(4):615-8. PubMed ID: 5003244
    [No Abstract]   [Full Text] [Related]  

  • 10. Studying Pets' Cancers May Yield Health Benefits For Humans.
    Jenks S
    J Natl Cancer Inst; 2015 Nov; 107(11):djv355. PubMed ID: 26538624
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of lymphatic leukemia in dogs].
    Freudiger U
    Schweiz Arch Tierheilkd; 1966 Dec; 108(12):665-75. PubMed ID: 6010218
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer drug approved for dogs.
    J Am Vet Med Assoc; 2009 Jul; 235(2):139. PubMed ID: 19610240
    [No Abstract]   [Full Text] [Related]  

  • 13. [siRNA targeting telomerase--effective tool in anti-cancer therapy?].
    Rubiś B; Półrolniczak A; Rybczyńska M
    Postepy Biochem; 2008; 54(4):384-92. PubMed ID: 19248585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications associated with the use of vascular access ports in dogs receiving external beam radiation therapy.
    Mayer MN; Grier CK; Yoshikawa H; Ringwood PB
    J Am Vet Med Assoc; 2008 Jul; 233(1):96-103. PubMed ID: 18593316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship (SAR) of parthenin analogues with pro-apoptotic activity: Development of novel anti-cancer leads.
    Shah BA; Kaur R; Gupta P; Kumar A; Sethi VK; Andotra SS; Singh J; Saxena AK; Taneja SC
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4394-8. PubMed ID: 19501509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression.
    Wang X; Hao MW; Dong K; Lin F; Ren JH; Zhang HZ
    Arch Pharm Res; 2009 Sep; 32(9):1263-9. PubMed ID: 19784583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K; Milner R; Lurie D; Adin C
    Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of cancer inhibition by melatonin.
    Reiter RJ
    J Pineal Res; 2004 Oct; 37(3):213-4. PubMed ID: 15357667
    [No Abstract]   [Full Text] [Related]  

  • 20. Activin inhibits telomerase activity in cancer.
    Katik I; Mackenzie-Kludas C; Nicholls C; Jiang FX; Zhou S; Li H; Liu JP
    Biochem Biophys Res Commun; 2009 Nov; 389(4):668-72. PubMed ID: 19769941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.